Compound information
- Natural Products
- ZC2784542
- Molecular Formula
- C26H32N2O5
- Molecular Weight
- 452.231122124 g/mol
- Structure
-
- IUPAC Name
- benzyl (2R)-1-[(2S)-2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]pyrrolidine-2-carboxylate
- InChI
- InChI=1S/C26H32N2O5/c1-19(2)16-22(27-26(31)33-18-21-12-7-4-8-13-21)24(29)28-15-9-14-23(28)25(30)32-17-20-10-5-3-6-11-20/h3-8,10-13,19,22-23H,9,14-18H2,1-2H3,(H,27,31)/t22-,23+/m0/s1
- InChI Key
- ROYICBBZEVCNPX-XZOQPEGZSA-N
- SMILES
- CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)OCc1ccccc1
- Source
- ZINC001528329550
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 33 | Ring Count | 3 |
Heteroatom Count | 7 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 84.94 Å2 | LogP | 4.644 |
LogS | -5.348 | LogD | 4.634 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.476 | Pgp substrate | 0.032 |
HIA | 0.97 | F20 % | 0.989 |
F30 % | 0.135 | Caco-2 | -4.792 |
MDCK | -4.705 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.009 | PPB | 96.832 |
VD | 0.909 | Fu | 1.696 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.38 | CYP1A2 substrate | 0.741 |
CYP2A6 substrate | 0.542 | CYP2B6 substrate | 0.641 |
CYP2C19 inhibitor | 0.949 | CYP2C19 substrate | 0.906 |
CYP2C8 substrate | 0.834 | CYP2C9 inhibitor | 0.912 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.104 |
CYP2D6 substrate | 0.82 | CYP2E1 substrate | 0.242 |
CYP3A4 inhibitor | 0.587 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.695 | CL | 5.239 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.066 | Hepatotoxicity | 0.966 |
Mutagenicity | 0.11 | Rat Oral Acute Toxicity | 0.398 |
FDAMDD | 0.709 | Skin Sensitization | 0.003 |
Carcinogenicity | 0.007 | Eye Corrosion | 0.005 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.029 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.428 | IGC50 | 4.303 |
LC50FM | 3.723 | LC50DM | 5.643 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.321 | NR-AR-LBD | 0.179 |
NR-AhR | 0.005 | NR-Aromatase | 0.04 |
NR-ER | 0.269 | NR-ER-LBD | 0.47 |
NR-PPAR-gamma | 0.211 | SR-ARE | 0.566 |
SR-ATAD5 | 0.41 | SR-HSE | 0.264 |
SR-MMP | 0.191 | SR-p53 | 0.04 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.